The Week in Cancer News: A targeted therapy for pancreatic cancer nearly doubled survival for people with metastatic disease, and more cancer research news of the week from Cancer Today magazine. buff.ly/dswnxuj

Submit an abstract by July 13 for the AACR Conference on Pancreatic Cancer (Sept 25-28; San Diego), chaired by Andrew J. Aguirre, Florencia McAllister, Kenneth P. Olive, Eileen O’Reilly, Diane M. Simeone, and Colin D. Weekes. buff.ly/pSzoa0m #AACRpan26 @kenolivelab.bsky.social

The FDA's accelerated approval made targeted therapy a treatment option for diffuse midline glioma. In the spring issue of Cancer Today, learn what this means for people with this aggressive brain cancer. www.cancertodaymag.org/spring-2026/...

Learn about the findings presented in the AACR Cancer Disparities Progress Report 2026. Join us on June 24 at 12 pm ET in Washington, D.C., for the release event. Register now to attend in person or to watch via the livestream. #AACRDisparitiesReport

Register by June 12 to get the lowest rates for the AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers (July 18-20, Vancouver), chaired by Andy Futreal, Taran Gujral, Brooke E. Howitt, and Patrick Tan. Learn more: buff.ly/tYdYrqC #AACRrarecancers26

In this Believe in Progress episode, metastatic breast cancer survivor Katie Rabinowitz shares her story of resilience, advocacy, community, and living well with cancer. Listen during #NationalCancerSurvivorMonth. buff.ly/Y2roUNK

Submit an abstract by July 13 for the San Antonio Breast Cancer Symposium (December 8-11), presented by UT Health San Antonio in collaboration with the AACR. Learn more: buff.ly/98T3KHj #SABCS26

Have questions about cancer care? You may have to wait until your next appointment, but some patients are turning to AI chatbots. Learn more about the potential and risks of AI for medical information in Cancer Today. buff.ly/MbVhUrK @stephenornes.bsky.social @thelizarmy.bsky.social

The inaugural AACR Drug Discovery and Development meeting will convene experts across the drug development pipeline to reshape the future of oncology therapeutics. Learn more from the meeting’s cochairs on the #AACRBlog: www.aacr.org/blog/2026/05... #AACRdrugdev26

Thanks to spectacular advances in cancer research, more than 18.6 million people in the U.S. and millions more around the world are living with, through, and beyond their diagnoses. Learn more during #NationalCancerSurvivorMonth: buff.ly/uSNceIM #CelebrateSurvivorship

The American Cancer Society updates colorectal screening guidelines to include blood testing, and GLP-1 use is associated with reduced risk of cancer progression. Read about this and more in Cancer Today magazine's Week in Cancer News. www.cancertodaymag.org/cancer-talk/...

Submit an abstract by July 9 for the AACR Special Conference on Bridging Discovery and Clinical Impact in Pediatric Cancer (September 22-25; Philadelphia), chaired by Olivier Delattre, Annie A. Huang, David M. Langenau, and Suzanne P. MacFarland. Learn more: buff.ly/KBDgzTO #AACRpediatric26

The @US_FDA approved the immunotherapy durvalumab with Bacillus Calmette-Guerin (BCG) for adults with high-risk non-muscle invasive bladder cancer who have not previously received BCG: buff.ly/p6ervJR

The addition of immunotherapy to nasopharyngeal cancer treatment led researchers to explore giving shorter courses of chemotherapy. Read about their findings in Cancer Today magazine. www.cancertodaymag.org/spring-2026/...

Submit an abstract by July 8 for the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (November 18-20; Barcelona, Spain), chaired by Elena Garralda, Ryan Corcoran, and Tim Greten. Learn more: buff.ly/yGE9ODf

The AACR is proud to be the charity partner of the Philadelphia Cycling Classic. Cyclists can join AACR #RidersForResearch for a unique opportunity to take a lap on the 14-mile race course while raising needed funds to advance cancer research. Learn more: buff.ly/dB8X5zU

Register by June 10 to get the lowest rates for the AACR D3 Conference on Drug Discovery and Development (July 21-24; Boston), chaired by AACR President Keith T. Flaherty, Lillian L. Siu, Patricia M. LoRusso, and Timothy A. Yap. Learn more: buff.ly/jE6qQ6F #AACRdrugdev26

What's next in breast cancer care? Researchers explore treating dormant cancer cells—cells that stop growing and escape treatment but may cause cancer recurrence. Read more in Cancer Today. www.cancertodaymag.org/spring-2026/...

Register by June 12 to get the lowest rates for the AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers (July 18-20, Vancouver), chaired by Andy Futreal, Taran Gujral, Brooke E. Howitt, and Patrick Tan. Learn more: buff.ly/tYdYrqC #AACRrarecancers26

Emerging Therapeutic Strategies for Rare Cancers: Paul Huang, Pavlos Msaouel, and Gayathri Devi will address this topic in a plenary session at the AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers (July 18-20, Vancouver). Learn more: buff.ly/LhhVizE #AACRrarecancers26

The FDA approves HER2-targeted therapy for early-stage breast cancer treatment, and blood thinners linked to reduced mortality in cancer patients at high risk of developing blood clots. Read about this and more in Cancer Today magazine's Week in Cancer News. www.cancertodaymag.org/cancer-talk/...

Researchers explore the role of a gene in controlling how well tamoxifen works in women with breast cancer. Read more in Cancer Today. www.cancertodaymag.org/cancer-talk/...

Submit an abstract by July 9 for the AACR Special Conference on Bridging Discovery and Clinical Impact in Pediatric Cancer (September 22-25; Philadelphia), chaired by Olivier Delattre, Annie A. Huang, David M. Langenau, and Suzanne P. MacFarland. Learn more: buff.ly/KBDgzTO #AACRpediatric26

What does it take to successfully take a hypothesis in a lab to a cancer therapeutic? In this episode of the Believe in Progress podcast, we talk with Dr. Peter Ordentlich, Co-Founder and Chief Scientific Officer at Syndax, about the process. www.youtube.com/watch?v=Dt4G...

Degraders in the Era of Precision Oncology: Richard Caldwell, Chinatsu Sakata, Ryan Potts, and David Puleo will address this topic in a plenary session at the AACR D3 Conference on Drug Discovery and Development (July 21-24; Boston). Learn more: buff.ly/7tdU4Rg #AACRdrugdev26 @pottslab.bsky.social

Register by June 12 to get the lowest rates for the AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers (July 18-20, Vancouver), chaired by Andy Futreal, Taran Gujral, Brooke E. Howitt, and Patrick Tan. Learn more: buff.ly/tYdYrqC #AACRrarecancers26

"I'd encourage patients to be honest and not hold back." Cancer Today spoke with hematologist-oncologist Manan Shah about the importance of speaking to your doctors about your goals and priorities for cancer care. www.cancertodaymag.org/spring-2026/...

Submit an abstract by July 13 for the San Antonio Breast Cancer Symposium (December 8-11), presented by UT Health San Antonio in collaboration with the AACR. Learn more: buff.ly/98T3KHj #SABCS26

The @US_FDA approved the immunotherapy atezolizumab or atezolizumab and hyaluronidase-tqjs for adults with muscle-invasive bladder cancer who have circulating tumor DNA-based molecular residual disease after surgery, as detected by an FDA-authorized test: buff.ly/xPq12Wv

The FDA approved a drug to treat bile duct cancer, and many older people diagnosed with stage IV lung cancer do not receive systemic treatment. Read about these and more in Cancer Today magazine's Week in Cancer News. www.cancertodaymag.org/cancer-talk/...

Submit an abstract by July 8 for the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (November 18-20; Barcelona, Spain), chaired by Elena Garralda, Ryan Corcoran, and Tim Greten. Learn more: buff.ly/yGE9ODf

From Pathognomonic Mutation Discovery to Generalizable Impact: Rapid Translation or Arrested Development—  David Huntsman will address this topic in a keynote address at the AACR Special Conference on Rare Cancers (July 18-20, Vancouver). Learn more: buff.ly/oIrejnS #AACRrarecancers26

@aacicancer.bsky.social and AACR Hill Day participants presented Sen. Shelley Moore Capito and @baldwin.senate.gov with the AACI-AACR Cancer Research Ally Award. This award recognizes two members of Congress for their bipartisan support of cancer research. #FundNIH #AACROnTheHill

Today, we join the @aacicancer.bsky.social for our annual Joint Hill Day in support of cancer research. At this crucial time, you can help by contacting your Members of Congress and asking them to support vital funding for the NIH and the NCI. www.aacr.org/professional... #AACRontheHill #FundNIH

To understand cancer treatment, researchers usually look at the average responses. But in the spring issue of Cancer Today, Editor-in-Chief William G. Nelson, MD, PhD, DSc, considers what we can learn from exceptional responses to treatment. buff.ly/QAjFmUd

Degraders in Lymphoma: Shannon Buckley, Francesco Bertoni, and Justin Taylor will address this topic in a plenary session at the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia). Learn more: buff.ly/XH3lbfr #AACRlymphoma26 @frbertoni.bsky.social

William G. Kaelin will discuss "Genetics as the Rosetta Stone for Cancer Therapeutics" in a keynote at the AACR Conference on Drug Discovery and Development (July 21-24; Boston), chaired by Keith T. Flaherty, Lillian L. Siu, Patricia M. LoRusso, and Timothy A. Yap. buff.ly/NgP4oYY #AACRdrugdev26

Today, the @US_FDA approved the molecularly targeted therapy zenocutuzumab-zbco for adults with advanced, unresectable, or metastatic cholangiocarcinoma – bile duct cancer – harboring a neuregulin 1 (NRG1) gene fusion. Learn more: buff.ly/w9FZK56

Patients with pancreatic cancer responded to RAS targeted therapy, and the thymus's surprising role in cancer immune response. Read about this and more in Cancer Today magazine's Week in Cancer News. www.cancertodaymag.org/cancer-talk/...

Register by May 11 to get the lowest rates for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with the ICML and chaired by Michael R. Green. Learn more: buff.ly/hA2t3nu

AI in Oncology: Facts and Hopes— Sarah Skerratt, Jorge Reis-Filho, and Benjamin Haibe-Kains will address this topic in a plenary session at the AACR D3 Conference on Drug Discovery and Development (July 21-24; Boston). Learn more: buff.ly/DIXf26I #AACRdrugdev26 @bhaibeka.bsky.social

What will NCI focus on under Director Anthony Letai? He outlined the institute’s areas of priority during a Special Session at the AACR Annual Meeting. Learn more on the #AACRBlog: www.aacr.org/blog/2026/05... #AACR26

"We're seeing discrimination playing out in the health care setting, actual and feared." Transgender and bisexual cancer survivors face unique barriers to care. Read more in Cancer Today. www.cancertodaymag.org/cancer-talk/...

Register by June 12 to get the lowest rates for the AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers (July 18-20, Vancouver), chaired by Andy Futreal, Taran Gujral, Brooke E. Howitt, and Patrick Tan. Learn more: buff.ly/tYdYrqC #AACRrarecancers26

AACR President Keith Flaherty will join a panel at the 8th Annual Emerging Frontiers in Oncology (EFO) Summit on June 4 in Cambridge. EFO has selected AACR to receive proceeds from the summit, with a goal of $100,000 to support early-career investigators. www.aacr.org/about-the-aa...

Kerry Rogers, Mark Roschewski, and Jason Westin will discuss "New Targeted Therapeutic Strategies in Lymphoma" in a plenary session at the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia). Learn more: buff.ly/o1EfvKZ #AACRlymphoma26 @lymphomadoc.bsky.social

In this episode of Believe in Progress, we explore a shared mission from two perspectives: Lauren C. Leiman, Executive Director of @bloodpac.bsky.social, and Mary Royal, a breast cancer survivor and patient advocate, discuss liquid biopsy, survivorship, and more. www.youtube.com/watch?v=Nb3o...

In 2025, AACR became the first publisher to conduct and present a study evaluating a tool designed to detect the use of AI-generated text in submitted papers, sparking discussions on the appropriate use of AI in scientific publishing. Learn more in the AACR Annual Impact Report: buff.ly/c7lp21a

Cancer patients with more financial resources are more likely to join a clinical trial, according to a recent study. In Cancer Today, learn what barriers make it difficult for many people to participate. www.cancertodaymag.org/cancer-talk/...

Harnessing Immunotherapy for Rare Cancers: Sandra P. D’Angelo, Alexander N. Shoustari, and Mark Yarchoan will address this topic in a plenary session at the AACR Special Conference on Rare Cancers (July 18-20, Vancouver). Learn more: buff.ly/uT6gl0k #AACRrarecancers26 @markyarchoan.bsky.social